Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

PURPOSE: The hu14.18-IL2 fusion protein consists of interleukin-2 molecularly linked to a humanized monoclonal antibody that recognizes the GD2 disialoganglioside expressed on neuroblastoma cells. This phase II study assessed the antitumor activity of hu14.18-IL2 in two strata of patients with recur...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shusterman, Suzanne, London, Wendy B., Gillies, Stephen D., Hank, Jacquelyn A., Voss, Stephan D., Seeger, Robert C., Reynolds, C. Patrick, Kimball, Jennifer, Albertini, Mark R., Wagner, Barrett, Gan, Jacek, Eickhoff, Jens, DeSantes, Kenneth B., Cohn, Susan L., Hecht, Toby, Gadbaw, Brian, Reisfeld, Ralph A., Maris, John M., Sondel, Paul M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3020698/
https://ncbi.nlm.nih.gov/pubmed/20921469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.8861
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars